Analyst Ratings for Regeneron Pharma (REGN)

REGN Rating Summary

REGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on REGN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $665.53 (+34%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 70%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/25/2021 BMO Capital Matthew Luchini Upgrade Outperform
(Market Perform)
630.00
(N/A)
535.48
(496.75)
-7.23% Details
1/13/2021 Benchmark Aydin Huseynov Upgrade Buy
(Hold)
590.00
(N/A)
502.92
(496.75)
-1.23% Details
Like REGN Ratings? Also take a look at SNY, LLY, GILD, MRNA

REGN Ratings News